XML 23 R13.htm IDEA: XBRL DOCUMENT v3.6.0.2
Derivative Liabilities
12 Months Ended
Nov. 30, 2015
Notes to Financial Statements  
Derivative Liabilities

5.       Derivative Liabilities

 

The Company evaluated their convertible note agreements pursuant to ASC 815 and due to there being no minimum or fixed conversion price resulting in an indeterminate number of shares to be issued in the future, the Company determined an embedded derivative existed and ASC 815 applied for their convertible notes. The Company valued the embedded derivatives using the Black-Scholes valuation model.  

  

Convertible debt with a variable conversion feature

 

In 2015, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.38 years; (2) a computed volatility rate of 372 to 787% (3) a discount rate of 1% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability. 

 

In 2014, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0.01 to .90 years; (2) a computed volatility rate of 171 to 339% (3) a discount rate of 1% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

 

Redeemable convertible preferred stock

 

In 2015, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term reflecting the immediate exercisability; (2) a computed volatility rate of 372% (3) a discount rate of 1% and (4) zero dividends. No preferred stock derivatives existed in fiscal 2014

 

Tainted conventional convertible debt

 

In 2015, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.0 years; (2) a computed volatility rate of 372 to 787% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2014, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.75 years; (2) a computed volatility rate of 171 to 339% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

 Tainted stock warrants

 

The Company also evaluated all outstanding warrants and options to determine whether these instruments may be tainted. All warrants outstanding were considered tainted as a result of the tainted equity environment and potential inability of the Company to settle the instruments with shares of the Company’s stock as the number of shares issuable cannot be estimated and could exceed that amount of authorized shares available to be issued by the Company. The Company valued the embedded derivatives within the stock warrants using the Black-Scholes valuation model.  

 

In 2015, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0.21 to 7.58 years; (2) a computed volatility rate of 372 to 787% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2014, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0.01 to 8.58 years; (2) a computed volatility rate of 171 to 339% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

 

 

Activity for embedded derivative instruments during the year ended November 30, 2015 was as follows:

 

      Initial valuation            
      of derivative            
      liabilities upon  Change in         
   Balance at  issuance of new  fair value of     Conversion  Balance at
   November 30,  securities during  derivative  Debt  of debt to  November 30,
   2014  the period  liabilities  Forgiveness  equity  2015
Variable convertible debt  $527,781   $81,792   $2,246,080   $(1,153,545)  $(1,535,614)  $166,494 
Redeemable convertible preferred stock   —      275,000    137,500              412,500 
Tainted convertible debt   106,246    118,790    (130,018)   —      —      95,018 
Tainted stock options   —      —           —      —        
Tainted warrants   5,312    2,000    10,888         —      18,200 
   $639,339   $477,582   $2,264,450   $(1,154,545)  $(1,535,614)  $692,212 

 

 

Activity for embedded derivative instruments during the year ended November 30, 2014 was as follows:

 

        Initial valuation                
        of derivative                
        liabilities upon   Change in   Exercise of        
    Balance at   issuance of new   fair value of   Stock   Conversion   Balance at
    November 30,   securities during   derivative   options/   of debt to   November 30,
    2013   the period   liabilities   Warrants   equity   2014
Variable convertible debt   $ 1,467,182     $ 230,837     $ (56,277 )   $ —       $ (213,961 )   $ 527,781  
Tainted convertible debt     139,953       155,179       (188,886 )     —         —         106,246  
Tainted stock options     —         —         —         —         —         —    
Tainted warrants     198,035       —         (192,,723 )     —         —         5,312  
    $ 1,805,170     $ 386,016     $ (1,337,886 )   $ —       $ (213,961 )   $ 639,339